The ICTI program funds pilot grants to support innovative basic and translational research on ion channels and metabolic transporters in the immune system – key areas with untapped therapeutic potential.
2023-2024
- Edward Skolnik
Professor of Cell Biology and Medicine, NYULH
“Copper Chaperones: Role in K+ Channel KCa3.1 and T Cell Activation and Potential to Therapeutically Target to Promote Tumor Killing.”
- Shohei Koide
Professor of Department of Biochemistry and Molecular Pharmacology, NYULH
“Development of Antibodies Targeting ATP1B3 to Alleviate Autoimmune Diseases and T Cell Malignancies.”
2024-2025
- David Stokes, PhD, Professor of Biochemistry and Molecular Pharmacology “Mechanisms of zinc transport by ZIP7 in T-cells.”
- William Coetzee, DSc, Professor of Pathology, Biochemistry and Molecular Pharmacology & Timothy Cardozo, MD, PhD, Associate Professor of Biochemistry and Molecular Pharmacology “KATP channels in NK cells.”
